Skip to main content
MDXH
NASDAQ Industrial Applications And Services

MDxHealth Faces Second Nasdaq Deficiency, Now Failing Market Value Rule

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.41
Mkt Cap
$21.059M
52W Low
$0.4
52W High
$5.33
52W Position info
2.6% above low
Off High info
92% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

MDXH is trading near its 52-week low of $0.4 (2.6% above the low).

Summary

MDxHealth received an additional Nasdaq notice for failing the $35 million minimum market value requirement, adding to its existing bid-price deficiency. The company has until January 19, 2027, to regain compliance or face delisting.


Key Events · Legal and Risk Events · MDXH

  • Second Nasdaq Deficiency Notice

    Nasdaq notified MDxHealth that its market value of listed securities fell below the $35 million minimum for 30 consecutive business days, adding to the existing bid-price deficiency.

  • Compliance Deadline Set

    The company has until January 19, 2027, to regain compliance with the MVLS requirement by maintaining a market value of at least $35 million for 10 consecutive business days.

  • Delisting Risk Intensifies

    Failure to cure either deficiency could lead to delisting from Nasdaq, which would materially impair the company's ability to raise capital and harm its financial condition.

  • Low Market Cap Challenges Cure

    With a market cap of approximately $21 million and shares at $0.41, a reverse split or substantial share price recovery is likely needed to meet the $35 million threshold.


Analysis · MDXH · Industrial Applications And Services

A second Nasdaq non-compliance notice has landed on MDxHealth, this time because the market value of its listed securities has slipped below the $35 million minimum. The company was already grappling with a bid-price deficiency, and now has until January 19, 2027, to cure both or risk delisting. With a market cap near $21 million and shares trading at $0.41, regaining compliance will likely require a reverse stock split or a dramatic share price recovery — neither of which is assured. The dual deficiencies compound the risk of a Nasdaq delisting, which would severely impair the company's ability to raise capital and could trigger a downward spiral.

At the time of this filing, MDXH was trading at $0.41 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $21.1M. The 52-week trading range was $0.40 to $5.33. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDXH - Latest Insights

MDXH
Jul 02, 2026, 4:15 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.4765
Real-time Price: $0.4104 info
Change: -$0.0661 (-14%) info
Market Cap: $21.059M info
MDXH
May 14, 2026, 3:54 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.14
Real-time Price: $0.4104 info
Change: -$0.7296 (-64%) info
Market Cap: $21.059M info
MDXH
May 13, 2026, 4:21 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.23
Real-time Price: $0.4104 info
Change: -$0.8196 (-67%) info
Market Cap: $21.059M info
MDXH
May 13, 2026, 4:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.85
Real-time Price: $0.4104 info
Change: -$1.44 (-78%) info
Market Cap: $21.059M info
MDXH
Apr 29, 2026, 9:02 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.97
Real-time Price: $0.4104 info
Change: -$1.56 (-79%) info
Market Cap: $21.059M info